Skip to main content

Petros Pharmaceuticals, Inc.

PTPI
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001815903

No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Petros Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of PTPI: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders1416+2
Shares99.6K116.7K+17.1K (+17.2%)
Value$170.6K$164.7K−$5.86K (−3.4%)

New holders (3)

Institutions that held Petros Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to PTPI in Q4 2023
InstitutionSharesValue% of portfolio
Virtu Financial LLC24,825$35.0K0.00%
FMR LLC20$280.00%
1832 Asset Management L.P.10$140.00%

Sold out (1)

Institutions that held Petros Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of PTPI in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Citadel Advisors LLC14,288$23.7K